Foren & Soziale Netzwerke zur SOL-GEL Aktie

 

Sol-Gel has put in a massive performance over the last year, up around 600% and that's after the recent pull back. That is serious momentum. Based in Israel, they are a dermatology company specializing in treatments for skin conditions using a unique silica-delivery technology. Fundamentally, there is still optimism here. Just recently, HC Wainwright & Co raised their price target to $110 , which is nearly double the current levels. That kind of analyst support often keeps a trend alive. The current pullback looks like standard profit-taking after the explosive move we saw earlier in the month. Technically, the price action is cooling off. The stock has dipped from its highs but is holding well above the 50-day SMA. The RSI has come down from overbought territory to a more manageable 56. The MACD is crossing down, confirming the pause, but this consolidation could offer a better entry point if buyers step back in. Given what buyers were very recently prepared to pay for it, and the analysts very recen